Copyright
©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 2050-2053
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2050
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2050
Table 2 Effect of KXR on cell cycle progression of HSCs mediated by PDGF (mean ± s)
Groups | n | HSC fractions at (%) | ||
G0-G1 phase | S phase | G2-M phase | ||
Control | 6 | 94.67 ± 2.17 | 4.13 ± 0.92 | 1.20 ± 0.47 |
PDGF 10 ng/mL | 6 | 20.18 ± 1.12 | 68.24 ± 2.72 | 11.18 ± 1.93 |
KXR 5 mg/mL→PDGF | 6 | 83.64 ± 3.68b | 10.95 ± 1.35b | 5.41 ± 0.98b |
KXR 2.5 mg/mL→PDGF | 6 | 62.58 ± 4.52b | 32.76 ± 1.07b | 4.66 ± 0.81b |
KXR 1.25 mg/mL→PDGF | 6 | 48.18 ± 3.37b | 43.19 ± 1.09b | 8.63 ± 0.71a |
- Citation: Yang L, Zhang CZ, Zhu QJ. Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF. World J Gastroenterol 2003; 9(9): 2050-2053
- URL: https://www.wjgnet.com/1007-9327/full/v9/i9/2050.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i9.2050